SecSonar.com

Abbott Laboratories (ABT)

Abbott Laboratories at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Abbott Laboratories (ABT) is a Medical - Devices company based in US with a market capitalization of $149.4B. Revenue grew 5.7% year-over-year and the company generated $7.4B in free cash flow. This page tracks ABT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 114K employees · IPO Mar 17, 1980

Valuation

Valuation & price

$84.89 · as of May 15, 2026 · -37.9% vs 52w high

22.7

P/E ratio

Latest-FY diluted EPS

2.87

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$137$110$84.32Jul 25Dec 25Jul 26Jul 7, 25$133.70Jul 9, 25$133.22Jul 11, 25$132.02Jul 15, 25$131.49Jul 17, 25$120.51Jul 21, 25$124.42Jul 23, 25$125.83Jul 25, 25$126.54Jul 29, 25$128.01Jul 31, 25$126.19Aug 4, 25$129.93Aug 6, 25$130.93Aug 11, 25$131.36Aug 13, 25$129.40Aug 15, 25$131.75Aug 19, 25$131.25Aug 21, 25$132.00Aug 25, 25$131.87Aug 27, 25$131.46Aug 29, 25$132.66Sep 3, 25$132.18Sep 5, 25$132.94Sep 9, 25$131.95Sep 11, 25$132.65Sep 16, 25$132.76Sep 18, 25$134.57Sep 22, 25$136.62Sep 24, 25$133.89Sep 26, 25$133.55Sep 30, 25$133.94Oct 2, 25$132.99Oct 6, 25$133.74Oct 8, 25$134.27Oct 10, 25$132.57Oct 14, 25$133.27Oct 16, 25$127.63Oct 21, 25$127.54Oct 23, 25$126.34Oct 27, 25$127.18Oct 29, 25$124.43Oct 31, 25$123.62Nov 4, 25$125.80Nov 6, 25$124.95Nov 10, 25$125.89Nov 12, 25$128.82Nov 14, 25$130.59Nov 18, 25$130.00Nov 20, 25$123.97Nov 25, 25$128.05Nov 28, 25$128.90Dec 2, 25$126.32Dec 4, 25$125.40Dec 8, 25$122.09Dec 10, 25$122.55Dec 12, 25$125.46Dec 16, 25$126.86Dec 18, 25$125.12Dec 22, 25$125.21Dec 24, 25$124.81Dec 29, 25$124.57Jan 2, 26$124.19Jan 6, 26$127.80Jan 8, 26$126.18Jan 12, 26$124.64Jan 14, 26$125.00Jan 16, 26$121.76Jan 21, 26$120.73Jan 23, 26$107.42Jan 27, 26$108.27Jan 29, 26$106.09Feb 2, 26$109.41Feb 4, 26$108.20Feb 9, 26$111.07Feb 11, 26$113.59Feb 13, 26$112.68Feb 18, 26$113.29Feb 20, 26$112.21Feb 24, 26$114.58Feb 26, 26$116.26Mar 2, 26$114.12Mar 4, 26$113.10Mar 6, 26$109.56Mar 10, 26$110.55Mar 12, 26$108.12Mar 17, 26$110.71Mar 19, 26$107.19Mar 23, 26$104.85Mar 25, 26$104.83Mar 27, 26$103.99Mar 31, 26$102.67Apr 2, 26$102.87Apr 7, 26$101.83Apr 9, 26$102.72Apr 13, 26$100.69Apr 15, 26$101.56Apr 17, 26$96.81Apr 22, 26$91.70Apr 24, 26$91.13Apr 28, 26$93.86Apr 30, 26$90.79May 4, 26$87.54May 6, 26$86.30May 8, 26$84.32May 12, 26$84.35May 14, 26$84.90May 18, 26$87.91May 20, 26$88.38May 22, 26$87.41May 28, 26$86.30Jun 1, 26$87.78Jun 3, 26$86.99Jun 5, 26$91.07Jun 9, 26$91.25Jun 11, 26$89.65Jun 15, 26$88.67Jun 17, 26$88.50Jun 22, 26$87.83Jun 24, 26$90.49Jun 26, 26$94.12Jul 2, 26$95.40
$82.5652-week range$136.62
Loading valuation history…

Fundamentals

Key fundamentals

$149.4B

Market cap

5.7%

Revenue growth (YoY)

55.5%

Gross margin

$7.4B

Free cash flow (USD)

$6.1B

Net debt

0.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$20.9BFY 2017$27.4BFY 2018$30.6BFY 2019$31.9BFY 2020$34.6BFY 2021$43.1BFY 2022$43.7BFY 2023$40.1BFY 2024$42.0BFY 2025$44.3B
$20.9B$44.3B

Free cash flow by year

2016 → 2025

FY 2016$2.1BFY 2017$4.4BFY 2018$4.9BFY 2019$4.5BFY 2020$5.7BFY 2021$8.6BFY 2022$7.8BFY 2023$5.1BFY 2024$6.4BFY 2025$7.4B
$2.1B$7.4B

Gross margin by year

2021 → 2025

FY 202153.9%FY 202251.1%FY 202350.0%FY 202450.8%FY 202555.5%
53.9%55.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $174KStratton John G · Director · $173.6KJun 18, 2026Filing
  • Quarterly report10-Q FiledApr 29, 2026Filing
  • Insider buyInsider Buy $927KSTARKS DANIEL J · Director · $926.5KApr 28, 2026Filing
  • Insider buyInsider Buy $201KBoudreau Philip P · EVP AND CFO · $201.3KApr 27, 2026Filing
  • 8-K eventBy-Laws AmendmentApr 27, 2026Filing
  • 8-K eventProposed Settlement NoticeApr 17, 2026Filing
  • 8-K eventEarnings ReleaseApr 16, 2026Filing

Questions

Frequently asked questions

What is Abbott Laboratories's market cap?

Abbott Laboratories (ABT) has a market capitalization of $149.4B.

What is ABT's P/E ratio?

ABT trades at a price-to-earnings ratio of 22.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ABT's price-to-book (P/B) ratio?

ABT trades at 2.87 times book value per share.

Are insiders buying ABT stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at Abbott Laboratories in the last 90 days.

Same arena

Related companies in Medical - Devices

ISRG

Intuitive Surgical, Inc.

$149.6B

SYK

Stryker Corporation

$118.1B

MDT

Medtronic plc

$95.6B

BSX

Boston Scientific Corporation

$71.7B

EW

Edwards Lifesciences Corporation

$49.6B

DXCM

DexCom, Inc.

$28.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.